Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Sensei Biotherapeutics, Inc. | snse-ex321_7.htm |
| EX-31.2 - EX-31.2 - Sensei Biotherapeutics, Inc. | snse-ex312_8.htm |
| EX-31.1 - EX-31.1 - Sensei Biotherapeutics, Inc. | snse-ex311_9.htm |
| EX-10.12 - EX-10.12 - Sensei Biotherapeutics, Inc. | snse-ex1012_633.htm |
| EX-4.3 - EX-4.3 - Sensei Biotherapeutics, Inc. | snse-ex43_634.htm |
| 10-K - 10-K - Sensei Biotherapeutics, Inc. | snse-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Accounting Firm
We consent to the incorporation by reference in Registration Statement No. 333-252954 on Form S-8 of our report dated March 30, 2021, relating to the financial statements of Sensei Biotherapeutics, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
Baltimore, Maryland
March 30, 2021